Close Menu

Connective Tissue Gene Tests has released five new tests for mutations, deletions, or duplications in genes related to connective tissue disorders.

The company now tests genes related to familial thoracic aortic aneurysm, Loeys-Dietz syndrome, proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome, thrombocytopenia and absent radius syndrome, and Wilson disease.

CTGT runs its new tests on its High-Density Targeted Array for copy number variation detection. The HDT array is manufactured by Agilent Technologies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The chief executive of the National Health Service in England is to call for tumor-agnostic drugs to be "fast-tracked," according to the Times.

Researchers in Australia are sequencing the Wollemi pine tree to try to protect it from extinction, Australia's ABC News reports.

Computerworld ranks Illumina as one of the top midsize organizations to work at in IT.

In Genome Research this week: links between biological aging and mutations affecting epigenetic regulators; long-read sequencing-based strategy to map chromatin accessibility; and more.